Table 3 Neonatal characteristics by survival outcome.
From: Neonatal outcomes in women with preterm premature rupture of membranes at periviable gestational age
Group 1 (17–23 weeks) | p value | Group 2 (24–27 weeks) | p value | |||
---|---|---|---|---|---|---|
Survived to discharged N = 19 | Death N = 5 | Survived to discharged N = 24 | Death N = 3 | |||
Maternal characteristics | ||||||
GW at PPROM (median, week) | 22 ± 1.2 (19–23) | 21 ± 2.3 (17–22) | 0.036 | 26 ± 1.2 (24–27) | 24 ± 1.2 (24–26) | 0.139 |
Latency period (median, day) | 50 ± 27.9 (12–105) | 40 ± 31.9 (16–85) | 1 | 17 ± 15.6 (7–61) | 24 ± 5.6 (17–28) | 0.635 |
Neonatal outcomes | ||||||
GA at delivery (week) | 29 ± 3.3 (24–34) | 26.8 ± 2.8 (23–30) | 0.235 | 29.4 ± 2.5 (25–34) | 28 ± 1.7 (27–30) | 0.437 |
Gender (male) | 10 (52.6) | 4 (80) | 0.358 | 17 (70.8) | 3 (100) | 0.545 |
Birth weight (g) | 1330.6 ± 473.9 (520–2120) | 1042.6 ± 434.5 (488–1560) | 0.265 | 1393.2 ± 412 (730–2270) | 983 ± 107.2 (880–1094) | 0.101 |
Apgar 1 | 5.4 ± 2.5 (1–9) | 4 ± 2.1 (1–7) | 0.235 | 6.5 ± 2.7 (1–9) | 4 ± 2.6 (2–7) | 0.139 |
Apgar 5 | 7.5 ± 1.5 (4–10) | 7.8 ± 0.8 (7–9) | 0.731 | 8.6 ± 1.7 (4–10) | 6 ± 2 (4–8) | 0.036 |
SGA | 1 (5.3) | 1 (20) | 0.380 | 2 (8.3) | 1 (33.3) | 0.308 |
Cases of intubation | 10 (52.6) | 5 (100) | 0.118 | 7 (29.2) | 3 (100) | 0.041 |
NCPAP use | 16 (84.2) | 0 | 0.001 | 20 (83.3) | 1 (33.3) | 0.115 |
Surfactant treatment | 12 (63.2) | 5 (100) | 0.272 | 8 (33.3) | 2 (66.7) | 0.535 |
PPHTN | 5 (26.3) | 3 (60) | 0.289 | 1 (4.2) | 2 (66.7) | 0.025 |
NO | 4 (21.1) | 2 (40) | 0.568 | 0 | 1 (33.3) | 0.111 |
Blood products | 9 (47.4) | 4 (80) | 0.327 | 10 (41.7) | 1 (33.3) | 1 |
Steroid treatment | 4 (21.1) | 0 | 1 | 2 (8.3) | 1 (33.3) | 0.308 |
Pneumothorax | 1 (5.3) | 1 (20) | 0.380 | 1 (4.2) | 2 (66.7) | 0.025 |
BSI | 2 (10.5) | 2 (0.4) | 0.179 | 4 (16.7) | 2 (66.7) | 0.115 |
CLABSI | 0 | 2 (40) | 0.036 | 1 (4.2) | 2 (66.7) | 0.025 |
Hemodynamically significant PDA | 3 (15.8) | 0 | 1 | 2 (8.3) | 0 | 1 |
Major morbidities | ||||||
BPD | 10 (52.6) | 0 | 0.053 | 6 (25) | 1 (33.3) | 1 |
IVH grade 3–4 | 2 (10.5) | 2 (20) | 0.179 | 0 | 1 (33.3) | 0.111 |
NEC | 1 (5.3) | 0 | 1 | 0 | 0 | 1 |
ROP | 1 (5.3) | 0 | 1 | 2 (8.3) | 0 | 1 |
Hearing impairment* | 4 (21.1) | – | NA | 2 (8.3) | – | NA |